Compliance After Orthodontic Treatment Using Thermoplastic or Hawley Retainers (OrthoComply)
Objective Evaluation of Compliance After Orthodontic Treatment Using Thermoplastic or Hawley Retainers: A Randomized Controlled Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Athens, Greece, 11527 Goudi
- School of Dentistry, Department of Orthodontics, National and Kapodistrian University of Athens
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- patients that have completed orthodontic treatment (are at stage of debonding) with fixed appliances in the upper and lower arch
- age 12- 18
Exclusion Criteria:
- systematic diseases
- craniofacial anomalies (clefts, etc)
- handicapped patients with problems of compliance
- pregnant women
- previous orthodontic treatment or compromise orthodontic treatment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Thermoplastic Retainer
Impressions of the upper arch will be taken at the day of bracket debonding and the retainer will be delivered in 24 hours.
TheraMon microchip will be embedded within the appliance and patients will be instructed to wear the appliance 24 hours/ day.
|
Orthodontic device for retention in the upper arch, after the end of orthodontic treatment
|
|
Active Comparator: Hawley Retainer
Impressions of the upper arch will be taken at the day of bracket debonding and the retainer will be delivered in 24 hours.
TheraMon microchip will be embedded within the appliance and patients will be instructed to wear the appliance 24 hours/ day.
|
Orthodontic device for retention in the upper arch, after the end of orthodontic treatment
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Compliance of retainer wear
Time Frame: 3 months
|
Compliance of retainer wear at 3 months, as expressed by average hours of daily wear (with the aid of TheraMon)
|
3 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Compliance of retainer wear
Time Frame: 1 month
|
Compliance of retainer wear at 1 month, as expressed by average hours of daily wear (with the aid of TheraMon)
|
1 month
|
|
Association between objective compliance assessment and diary reported hours
Time Frame: 3 months
|
Association between objective compliance assessment (TheraMon) and diary reported hours (by patient)
|
3 months
|
|
Association between objective compliance assessment and diary reported hours
Time Frame: 1 month
|
Association between objective compliance assessment (TheraMon) and diary reported hours (by patient)
|
1 month
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Georgia Vagdouti, School of Dentistry, National and Kapodistrian University of Athens
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- 341/10.07.17
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.